The page is the record's research on the issuer — no analyst, no rating, no view.

ROCHE I (RO) — research page

CH · ch-cm-kg/SIX/RO · as of 2026-11-06

Identity and listing

The issuer is ROCHE I, listed on SIX under ticker RO, ISIN CH0012032113, LEI 549300U41AUUVOAAOB37. Its security type is Corporate. Segment is not on the record. Sector is not on the record, as the SIX feed returns an empty ICB industry for this line. Jurisdiction is Switzerland, as a Zefix-registered corporation. Status is listed, not halted.

fieldvaluesource · read date
nameROCHE Isource · 2026-11-06
exchangeSIXsource · 2026-11-06
tickerROsource · 2026-11-06
ISINCH0012032113source · 2026-11-06
LEI549300U41AUUVOAAOB37source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectornot on the record
jurisdictionSwitzerland (Zefix-registered corporation)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 12 filings in the twelve months to 2026-11-06, on 12 filing days. Of these, 1 is corporate news, 9 are newswire releases and 2 are register mutations. The median gap between filing days is 20 days. The latest filing is dated 2026-11-05 and is a newswire release, 1 day before the record date. Exchange peers on SIX number 607 issuers, with a median cadence gap of 29.5 days, a median of 0 filings, and a median latency of 14 days. Sector peers for this market are not on the record.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer12201
exchange median: SIX (607 issuers)029.514
datetypecategoryfiling
2026-11-05newswire_releaseChai Discovery Announces Collaboration with Roche in AI-Driven Drug Discovery
2026-11-02newswire_releaseRoche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs
2026-10-28corporate_newscorporateDKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin® From Roche | Corporate - EQS News
2026-10-08newswire_releasePCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
2026-09-30newswire_releaseRoche’s fenebrutinib is the first BTK inhibitor to receive

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is shown as Statutory Auditor's Report. Its location is not on the record. Auditor changes are not on the record, as the register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as the register has no lifecycle type map yet. The halt flag shows listed, not halted.

Orderability

For Privatkundinnen und -kunden the signal is ACM-200, and the outcome is determinable. For professionelle Kunden the signal is ACM-200, and the outcome is determinable. For institutionelle Kunden the signal is ACM-200, and the outcome is determinable. The rule version is acm-68000/ch/finsa-product-duties/r1, with the chapter as of 2026-11-04.

client categoryoutcome
Privatkundinnen und -kundenACM-200
institutionelle KundenACM-200
professionelle KundenACM-200

rule acm-68000/ch/finsa-product-duties/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page has not been read, so research house coverage is not on the record.

Open research

Openly published research notes have not been read, so the count is not on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No sealed years hold the issuer, and no earliest sealed date is on the record. The live record began date is not on the record.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.six-group.com/en/products-services/the-swiss-stock-exchange/market-data/shares/share-explorer.html (identity.exchange)
10.2
https://www.zefix.ch/en/search/entity/list?name=ROCHE%20%7C%20Roche%20Holding%20AG (identity.jurisdiction)
10.3
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.4
https://mcp.ch-cm-kg.ai/events/SIX/RO (the disclosure lines)
10.5
https://www.ser-ag.com/sheldon/official_notices/v2/find.json ; https://www.bxswiss.com/suspensions (the halt flag)
10.6
https://assets.roche.com/f/250698/x/840001eb3d/rocheannualreport2025.pdf (the auditor)
10.7
https://mcp.ch-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.ch-cm-kg.ai/record/SIX/RO (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"CH0012032113"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:632774f1ee4e1a35.